In prostate cancer, the ERG gene is frequently translocated to the TMPRSS2 promoter region, with the resulting TMPRSS2-ERG fusion protein expressed in ~50% of human prostate cancers39,40. The gene discussed is ERG; the disease is prostate cancer.